(Q54098841)

24 May 2018

title

In vitro activity of quinupristin/dalfopristin against clinical isolates of common gram-positive bacteria in Taiwan. (English)

1 reference

24 May 2018

author

Chang Shan-chwen

1

1 reference

24 May 2018

Chi-Tai Fang

2

1 reference

24 May 2018

author name string

Hsueh PR

3

1 reference

24 May 2018

Luh KT

4

1 reference

24 May 2018

Hsieh WC

5

1 reference

24 May 2018

publication date

1 April 1999

1 reference

24 May 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

24 May 2018

volume

33

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

299-303

1 reference

24 May 2018

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

Macrolides resistance of common bacteria isolated from Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

Comparative in-vitro activity of RP 59500

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

High incidence of erythromycin-resistant streptococci in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900147-3

7 January 2021

10.1016/S0732-8893(98)00147-3

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018